AKTX
NASDAQAkari Therapeutics PLC
$0.24
-0.01 (-3.09%)
Analyst Ratings
Hold
Consensus
Strong Buy
0
Buy
0
Hold
2
Sell
0
Strong Sell
0
Price Targets
Low
$5
Average
$5
High
$5
Current: $0.24
Piotroski F-Score
5
out of 9
Average financial health. Some areas for improvement in profitability or efficiency.
Positive Net Income
Fail
Positive Operating Cash Flow
Fail
ROA Increasing
Pass
Cash Flow > Net Income
Pass
Lower Long-term Debt
Pass
Higher Current Ratio
Fail
No New Shares Issued
Pass
Higher Gross Margin
Pass
Higher Asset Turnover
Fail